These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 21376379)
1. Pathogen-specific IgG antibody levels in immunodeficient patients receiving immunoglobulin replacement do not provide additional benefit to therapeutic management over total serum IgG. Chua I; Lagos M; Charalambous BM; Workman S; Chee R; Grimbacher B J Allergy Clin Immunol; 2011 Jun; 127(6):1410-1. PubMed ID: 21376379 [No Abstract] [Full Text] [Related]
2. Consistency of protective antibody levels across lots of intravenous immunoglobulin preparations. Lejtenyi D; Mazer B J Allergy Clin Immunol; 2008 Jan; 121(1):254-5. PubMed ID: 18206511 [No Abstract] [Full Text] [Related]
3. Prospective evaluation of Streptococcus pneumoniae serum antibodies in patients with primary immunodeficiency on regular intravenous immunoglobulin treatment. Simão-Gurge RM; Costa-Carvalho BT; Nobre FA; Gonzalez IG; de Moraes-Pinto MI Allergol Immunopathol (Madr); 2017; 45(1):55-62. PubMed ID: 27480789 [TBL] [Abstract][Full Text] [Related]
4. Characterization of antibodies to capsular polysaccharide antigens of Haemophilus influenzae type b and Streptococcus pneumoniae in human immune globulin intravenous preparations. Mikolajczyk MG; Concepcion NF; Wang T; Frazier D; Golding B; Frasch CE; Scott DE Clin Diagn Lab Immunol; 2004 Nov; 11(6):1158-64. PubMed ID: 15539522 [TBL] [Abstract][Full Text] [Related]
5. Pneumococcal antibody levels in children with PID receiving immunoglobulin. Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995 [TBL] [Abstract][Full Text] [Related]
6. Prevention of pneumococcal infection in a patient with normal immunoglobulin levels but impaired polysaccharide antibody production. Cohn JA; Skorpinski E; Cohn JR Ann Allergy Asthma Immunol; 2006 Nov; 97(5):603-5. PubMed ID: 17165266 [TBL] [Abstract][Full Text] [Related]
7. Coexistent yellow nail syndrome and selective antibody deficiency. Bokszczanin A; Levinson AI Ann Allergy Asthma Immunol; 2003 Nov; 91(5):496-500. PubMed ID: 14692436 [TBL] [Abstract][Full Text] [Related]
8. Humoral immunity and bronchiectasis. Stead A; Douglas JG; Broadfoot CJ; Kaminski ER; Herriot R Clin Exp Immunol; 2002 Nov; 130(2):325-30. PubMed ID: 12390323 [TBL] [Abstract][Full Text] [Related]
9. Half-life and clearance of pH 6.8 and pH 4.25 immunoglobulin G intravenous preparations in patients with primary disorders of humoral immunity. Schiff RI Rev Infect Dis; 1986; 8 Suppl 4():S449-56. PubMed ID: 3092310 [TBL] [Abstract][Full Text] [Related]
10. Skewed B cell receptor repertoire and reduced antibody avidity in patients with DOCK8 deficiency. Tang W; Dou Y; Qin T; Ding Y; Tang X; Zhao X; An Y Scand J Immunol; 2019 Jun; 89(6):e12759. PubMed ID: 30793341 [TBL] [Abstract][Full Text] [Related]
11. Increases in serum immunoglobulins to age-related normal levels in children with IgA and/or IgG subclass deficiency. Kutukculer N; Karaca NE; Demircioglu O; Aksu G Pediatr Allergy Immunol; 2007 Mar; 18(2):167-73. PubMed ID: 17338791 [TBL] [Abstract][Full Text] [Related]
12. Impact of trough IgG on pneumonia incidence in primary immunodeficiency: A meta-analysis of clinical studies. Orange JS; Grossman WJ; Navickis RJ; Wilkes MM Clin Immunol; 2010 Oct; 137(1):21-30. PubMed ID: 20675197 [TBL] [Abstract][Full Text] [Related]
14. Antibody levels to tetanus, diphtheria, measles and varicella in patients with primary immunodeficiency undergoing intravenous immunoglobulin therapy: a prospective study. Nobre FA; Gonzalez IG; Simão RM; de Moraes Pinto MI; Costa-Carvalho BT BMC Immunol; 2014 Jun; 15():26. PubMed ID: 24952415 [TBL] [Abstract][Full Text] [Related]
15. Monitoring of two intravenous immunoglobulin. Preparations for immunoglobulin G subclasses and specific antibodies to bacterial surface antigens and relation with their levels in treated immunodeficient patients. Lamari F; Karamanos NK; Papadopoulou-Alataki E; Kanakoudi-Tsakalidou F; Dimitracopoulos G; Anastassiou ED J Pharm Biomed Anal; 2000 Jul; 22(6):1029-36. PubMed ID: 10857572 [TBL] [Abstract][Full Text] [Related]
16. Functional antibodies to Haemophilus influenzae type B, Neisseria meningitidis, and Streptococcus pneumoniae contained in intravenous immunoglobulin products. Lee S; Kim HW; Kim KH Transfusion; 2017 Jan; 57(1):157-165. PubMed ID: 27774610 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of a new 10% intravenous immunoglobulin in patients receiving replacement therapy for primary immunodeficiency. Wasserman RL; Church JA; Peter HH; Sleasman JW; Melamed I; Stein MR; Bichler J; Eur J Pharm Sci; 2009 Jun; 37(3-4):272-8. PubMed ID: 19491015 [TBL] [Abstract][Full Text] [Related]
18. IgG replacement therapy, no size fits all. Bonilla FA Clin Immunol; 2011 May; 139(2):107-9. PubMed ID: 21420364 [No Abstract] [Full Text] [Related]
19. The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients. Winkelstein JA; Marino MC; Ochs H; Fuleihan R; Scholl PR; Geha R; Stiehm ER; Conley ME Medicine (Baltimore); 2003 Nov; 82(6):373-84. PubMed ID: 14663287 [TBL] [Abstract][Full Text] [Related]
20. [Deficiency in immunoglobulin subclasses as cause of increased infection susceptibility--a family study]. Grob M; Joller-Jemelka HI; Grob PJ Schweiz Med Wochenschr; 1991 Feb; 121(5):133-44. PubMed ID: 1900641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]